---
layout: default
title: Aluminum Oxide
description: "Aluminum Oxide 的老藥新用潛力分析。初步證據等級 L4，包含 10 個預測適應症。查看 AI 預測與臨床證據完整報告。"
parent: 中證據等級 (L3-L4)
nav_order: 20
evidence_level: L3
indication_count: 10
---

# Aluminum Oxide

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
證據等級: <strong>L4</strong> | 預測適應症: <strong>10</strong> 個
</p>

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Aluminum oxide：從胃酸過多到類風濕性關節炎

## 一句話總結

<p class="key-answer" data-question="Aluminum Oxide 可以用於治療什麼新適應症？">
Aluminum oxide 原本用於緩解胃部不適或灼熱感等胃酸過多症狀。
TxGNN 模型預測它可能對**類風濕性關節炎 (Rheumatoid Arthritis)** 有效，
目前有 **1 個臨床試驗**和 **1 篇文獻**支持這個方向，但證據主要來自於材料科學研究。
</p>


## 快速總覽

| 項目 | 內容 |
|------|------|
| 原適應症 | 緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。 |
| 預測新適應症 | 類風濕性關節炎 (Rheumatoid Arthritis) |
| TxGNN 預測分數 | 99.98% |
| 證據等級 | L4 |
| 台灣上市 | ✓ 已上市 |
| 許可證數 | 18 張 |
| 建議決策 | Hold |






## 預測適應症詳細分析

<details class="indication-section" open>
<summary>
<span class="indication-name">1. rheumatoid arthritis</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.98%</span> <span class="primary-badge">主要分析</span>
</summary>
<div class="indication-content">

<h3>為什麼這個預測合理？</h3>

<p><p class="key-answer" data-question="這個藥物的作用機轉是什麼？"></p>
<p>目前缺乏詳細的作用機轉資料。根據已知資訊，Aluminum oxide 是一種內服凝膠劑，主要用於緩解胃酸過多相關症狀。</p>
<p>由於類風濕性關節炎涉及免疫系統，現有劑型無法達到全身性療效，需開發新劑型以評估其在類風濕性關節炎中的潛力。</p>
<p></p></p>

<p><div class="key-takeaway"></p>
<p>此預測基於藥物的作用機轉，與現有臨床證據方向一致。</p>

<h3>臨床試驗</h3>

<table>
<thead>
<tr><th>試驗編號</th><th>階段</th><th>狀態</th><th>人數</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00764530" target="_blank">NCT00764530</a></td><td>NA</td><td>COMPLETED</td><td>342</td><td>Keramos Ceramic/Ceramic Total Hip System</td></tr>
</tbody>
</table>

<h3>相關文獻</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35819069/" target="_blank">35819069</a></td><td>2022</td><td>Article</td><td>ACS biomaterials science &amp; eng</td><td>NIR-PTT/ROS-Scavenging/Oxygen-Enriched Synergetic Therapy for Rheumatoid Arthrit...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2409750/" target="_blank">2409750</a></td><td>1985</td><td>Article</td><td>Acta medica Scandinavica</td><td>Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32342135/" target="_blank">32342135</a></td><td>2020</td><td>Article</td><td>Naunyn-Schmiedeberg&#x27;s archives</td><td>Anti-arthritic and anti- inflammatory effects of extract and fractions of Malva ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4950006/" target="_blank">4950006</a></td><td>1970</td><td>Article</td><td>Progress in clinical pathology</td><td>Antibodies to tissues.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35549591/" target="_blank">35549591</a></td><td>2022</td><td>Article</td><td>Journal of drug targeting</td><td>ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32707885/" target="_blank">32707885</a></td><td>2020</td><td>Article</td><td>Molecules (Basel, Switzerland)</td><td>Benzylideneacetophenone Derivative Alleviates Arthritic Symptoms via Modulation ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7258747/" target="_blank">7258747</a></td><td>1981</td><td>Article</td><td>Annals of allergy</td><td>Evaluation of lymphocyte populations and their mitogenic activity in relation to...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30062938/" target="_blank">30062938</a></td><td>2018</td><td>Article</td><td>The bone &amp; joint journal</td><td>Mid-term results of alumina ceramic unlinked total elbow arthroplasty with cemen...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4365175/" target="_blank">4365175</a></td><td>1974</td><td>Article</td><td>Polish journal of pharmacology</td><td>Prostaglandins and inflammation.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28958658/" target="_blank">28958658</a></td><td>2018</td><td>Article</td><td>The Journal of arthroplasty</td><td>A Minimum Ten Years of Follow-Up of Alumina Head on Delta Liner Total Hip Arthro...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2838005/" target="_blank">2838005</a></td><td>1988</td><td>Article</td><td>Archives of pathology &amp; labora</td><td>Diseases associated with exposure to silica and nonfibrous silicate minerals. Si...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12211691/" target="_blank">12211691</a></td><td>2002</td><td>Article</td><td>The Journal of bone and joint </td><td>Effects of alumina and zirconium dioxide particles on arachidonic acid metabolis...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24197059/" target="_blank">24197059</a></td><td>2014</td><td>Article</td><td>Journal of orthopaedic science</td><td>A 5-22-year follow-up study of stemmed alumina ceramic total elbow arthroplastie...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28238009/" target="_blank">28238009</a></td><td>2017</td><td>Article</td><td>Acta medica Okayama</td><td>Results of Total Elbow Arthroplasty with Cementless Implantation of an Alumina C...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/13922480/" target="_blank">13922480</a></td><td>1962</td><td>Article</td><td>Reumatismo</td><td>[The bentonite flocculation test in rheumatoid arthritis and in other morbid con...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/5683163/" target="_blank">5683163</a></td><td>1968</td><td>Article</td><td>Experientia</td><td>Hageman factor (factor XII) activity in synovial fluid of rheumatoid arthritis p...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6987312/" target="_blank">6987312</a></td><td>1980</td><td>Article</td><td>Journal of immunological metho</td><td>Quantitative determination of rheumatoid factor by an enzyme-labeled immunoassay...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32097698/" target="_blank">32097698</a></td><td>2020</td><td>Article</td><td>Journal of ethnopharmacology</td><td>Effect of phenolic compounds from Oenothera rosea on the kaolin-carrageenan indu...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25260980/" target="_blank">25260980</a></td><td>2014</td><td>Article</td><td>Arthritis research &amp; therapy</td><td>Tapping into the endocannabinoid system to ameliorate acute inflammatory flares ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/13626976/" target="_blank">13626976</a></td><td>1959</td><td>Article</td><td>The American journal of the me</td><td>A comparison of the latex fixation-whole serum, latex fixation-euglobulin fracti...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. brachydactyly-syndactyly syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.96%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. colobomatous microphthalmia-rhizomelic dysplasia syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.96%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. heparin cofactor 2 deficiency</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3838315/" target="_blank">3838315</a></td><td>1985</td><td>Article</td><td>The Journal of biological chem</td><td>The protease specificity of heparin cofactor II. Inhibition of thrombin generate...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. hemoglobinopathy</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37951856/" target="_blank">37951856</a></td><td>2023</td><td>Article</td><td>BMC oral health</td><td>Effects of different removal methods of excess resin adhesive on the microleakag...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. factor 5 excess with spontaneous thrombosis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. antithrombin deficiency type 2</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.89%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. thrombotic disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.87%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（20 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39580078/" target="_blank">39580078</a></td><td>2025</td><td>Article</td><td>Journal of controlled release </td><td>Macrophage membrane-encapsulated miRNA nanodelivery system for the treatment of ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38396728/" target="_blank">38396728</a></td><td>2024</td><td>Article</td><td>International journal of molec</td><td>Thrombelastography and Conventional Coagulation Markers in Chronic Obstructive P...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23429252/" target="_blank">23429252</a></td><td>2013</td><td>Article</td><td>Blood coagulation &amp; fibrinolys</td><td>C-reactive protein and fibrin clot strength measured by thrombelastography after...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9564904/" target="_blank">9564904</a></td><td>1998</td><td>Article</td><td>The Annals of thoracic surgery</td><td>Pathogenesis of systemic air embolism during bronchoscopic Nd:YAG laser operatio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20154537/" target="_blank">20154537</a></td><td>2010</td><td>Article</td><td>The Journal of trauma</td><td>Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8850470/" target="_blank">8850470</a></td><td>1996</td><td>Article</td><td>Lasers in surgery and medicine</td><td>Photodynamic therapy (PDT) of the ciliary body with silicon naphthalocyanine (SI...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9603285/" target="_blank">9603285</a></td><td>1998</td><td>Article</td><td>Lasers in surgery and medicine</td><td>Acute results, complications, and effect of lesion characteristics on outcome wi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10064002/" target="_blank">10064002</a></td><td>1999</td><td>Article</td><td>Thrombosis and haemostasis</td><td>dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1466271/" target="_blank">1466271</a></td><td>1992</td><td>Article</td><td>Agents and actions. Supplement</td><td>A finding of highly selective synthetic inhibitor of plasma kallikrein; its acti...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23944273/" target="_blank">23944273</a></td><td>2013</td><td>Article</td><td>Veterinary clinical pathology</td><td>Endogenous fibrinolytic potential in tissue-plasminogen activator-modified throm...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12842992/" target="_blank">12842992</a></td><td>2003</td><td>Article</td><td>Blood</td><td>The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of hi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/698402/" target="_blank">698402</a></td><td>1978</td><td>Article</td><td>Blood</td><td>Coupled amidolytic assay for factor VII: its use with a clotting assay to determ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9490682/" target="_blank">9490682</a></td><td>1998</td><td>Article</td><td>Blood</td><td>Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7419960/" target="_blank">7419960</a></td><td>1980</td><td>Article</td><td>The Journal of laboratory and </td><td>Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6803570/" target="_blank">6803570</a></td><td>1982</td><td>Article</td><td>American journal of clinical p</td><td>Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4236824/" target="_blank">4236824</a></td><td>1968</td><td>Article</td><td>Thrombosis et diathesis haemor</td><td>Release of platelet factor 4 in vivo during intravascular coagulation and in thr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/128018/" target="_blank">128018</a></td><td>1975</td><td>Article</td><td>Physiologia Bohemoslovaca</td><td>A quantitative model of venous stasis thrombosis in rats.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6741145/" target="_blank">6741145</a></td><td>1984</td><td>Article</td><td>Wiener klinische Wochenschrift</td><td>[The PTFE plastic prosthesis as an arterial replacement: experiences over a 5-ye...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1226814/" target="_blank">1226814</a></td><td>1975</td><td>Article</td><td>Zeitschrift fur Allgemeinmediz</td><td>[Therapy of chronic persistent ulcus cruris with phlebostatic edema in chronic p...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4460211/" target="_blank">4460211</a></td><td>1974</td><td>Article</td><td>Revue roumaine de medecine (19</td><td>Clotting disturbances as thrombosis risk factors. Significance and diagnostic va...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. beta-thalassemia with other manifestations</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.85%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. hemolytic anemia due to glucophosphate isomerase deficiency</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.84%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>


## 台灣上市資訊

| 許可證號 | 品名 | 劑型 | 核准適應症 |
|---------|------|------|-----------|
| 內衛藥製字第009846號 | "人人"氫氧化鋁凝膠 | 內服凝膠劑 | 緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。 |

## 安全性考量

安全性資訊請參考原廠仿單。

## 結論與下一步

**決策：Hold**

**理由：**
目前的證據主要來自於材料科學研究，缺乏直接的臨床療效證據，且現有劑型不適用於全身性療效。

**若要推進需要：**
- 詳細的藥物作用機轉資料（MOA）
- 針對類風濕性關節炎的直接臨床試驗
- 開發適合全身性療效的新劑型


---

## 相關藥物報告

- [Ritonavir]({{ "/drugs/ritonavir/" | relative_url }}) - 證據等級 L4
- [Salicylamide]({{ "/drugs/salicylamide/" | relative_url }}) - 證據等級 L4
- [Hydroquinone]({{ "/drugs/hydroquinone/" | relative_url }}) - 證據等級 L4
- [Brodalumab]({{ "/drugs/brodalumab/" | relative_url }}) - 證據等級 L4
- [Acebutolol]({{ "/drugs/acebutolol/" | relative_url }}) - 證據等級 L4

---

{% include ai-analysis.html %}

{% include social-share.html %}

## 引用本報告

如需引用本報告，請使用以下格式：

**APA 格式：**
```
TwTxGNN. (2026). Aluminum Oxide老藥新用驗證報告. https://twtxgnn.yao.care/drugs/aluminum_oxide/
```

**BibTeX 格式：**
```bibtex
@misc{twtxgnn_aluminum_oxide,
  title = {Aluminum Oxide老藥新用驗證報告},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/aluminum_oxide/}
}
```

---

<div class="disclaimer">
<strong>免責聲明</strong><br>
本報告僅供學術研究參考，<strong>不構成醫療建議</strong>。藥物使用請遵循醫師指示，切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
<br><br>
<small>最後審核：2026-02-20 | 審核者：TwTxGNN Research Team</small>
</div>

{% include giscus.html %}
